Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran versus standard of care for pediatric venous thromboembolism
2013-002114-12Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in venous thromboembolism (VTE) comparing Dabigatran etexilate with Standard of care (2 arms). Primary endpoint: Combined efficacy endpoint. Started Jul 2013; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2013-002114-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002114-12.